GZ-389988 is a potent pan-TRK inhibitor with IC50 values of 0.3, 0.1, and 0.5 nM for TRKA, TRKB, and TRKC, respectively. GZ-389988 can be used to study NTRK fusion-positive tumors [1].
References:
[1]. Liu J, et al. Research Progress on Small Molecules Inhibitors Targeting TRK Kinases. Curr Med Chem. 2023;30(10):1175-1192.
References:
[1]. Liu J, et al. Research Progress on Small Molecules Inhibitors Targeting TRK Kinases. Curr Med Chem. 2023;30(10):1175-1192.
















